| Identification | More | [Name]
2,4-Dichloro-6,7-dimethoxyquinazoline | [CAS]
27631-29-4 | [Synonyms]
2,4-DICHLORO-6,7-DIMETHOXYQUINAZOLINE
TIMTEC-BB SBB000972
2,4-Dichloro-6,7-dimethoxyquin
2,4-DICHLORO-6,7-DIMETHOXYQUINAZOLINETERAZOSIN
2,4-Dichloro-6,7-dimethoxyquinazoline, 98+%
2,4-Dichloro-6,7-dimethoxyxinazoline
2,4-Dichloro-6-methoxy-7-quinazolinyl methyl ether ,98%
2,4-Dichloro-6,7-dimethoxyquinoazoline | [EINECS(EC#)]
608-117-4 | [Molecular Formula]
C10H8Cl2N2O2 | [MDL Number]
MFCD00051733 | [Molecular Weight]
259.09 | [MOL File]
27631-29-4.mol |
| Chemical Properties | Back Directory | [Appearance]
pale yellow to beige crystalline powder | [Melting point ]
175-178 °C (lit.) | [Boiling point ]
340.5±42.0 °C(Predicted) | [density ]
1.5369 (rough estimate) | [refractive index ]
1.6100 (estimate) | [storage temp. ]
2-8°C | [solubility ]
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | [form ]
Crystalline Powder | [pka]
-0.49±0.30(Predicted) | [color ]
Pale yellow to beige | [Water Solubility ]
Insoluble in water. | [Sensitive ]
Moisture Sensitive | [Detection Methods]
HPLC,NMR | [BRN ]
190331 | [CAS DataBase Reference]
27631-29-4(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S37/39:Wear suitable gloves and eye/face protection .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing . | [WGK Germany ]
3 | [HS Code ]
29334900 |
| Hazard Information | Back Directory | [Chemical Properties]
pale yellow to beige crystalline powder | [Uses]
2,4-Dichloro-6,7-dimethoxyquinazoline is used as an intermediate in the preparation of potential inhibitors of epidermal growth factor receptor kinases. It is also used as an intermediate in the preparation of terazosin. | [Uses]
An intermediate in the preparation of potential inhibitors of epidermal growth factor receptor kinases. An intermediate in the preparation of Terazosin (T105000). |
|
|